BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20617463)

  • 1. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
    Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
    Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
    Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
    Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
    Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
    Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.
    Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
    Pathobiology; 2011; 78(4):201-9. PubMed ID: 21778787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
    Omran OM; Thabet M
    Ultrastruct Pathol; 2012 Apr; 36(2):108-16. PubMed ID: 22471433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
    Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
    Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.